Cargando…
AntagomiR-451 inhibits oxygen glucose deprivation (OGD)-induced HUVEC necrosis via activating AMPK signaling
Oxygen glucose deprivation (OGD) application in cultured human umbilical vein endothelial cells (HUVECs) mimics ischemic injuries. AntagomiR-451, the miroRNA-451 (“miR-451”) inhibitor, could activate pro-survival AMP-activated protein kinase (AMPK) signaling. In the current study, we showed that for...
Autores principales: | Yang, Xi, He, Xiao-Qing, Li, Guo-Dong, Xu, Yong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405932/ https://www.ncbi.nlm.nih.gov/pubmed/28445531 http://dx.doi.org/10.1371/journal.pone.0175507 |
Ejemplares similares
-
AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism
por: Rech, Monika, et al.
Publicado: (2018) -
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2020) -
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia
por: Dereani, Sara, et al.
Publicado: (2014) -
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2021) -
AntagomiR‐29b inhibits vascular and valvular calcification and improves heart function in rats
por: Fang, Ming, et al.
Publicado: (2020)